Trulieve Cannabis Corp.

TRUL

CA89788C1041

Pharmaceuticals

Market Closed - Canadian Securities Exchange Other stock markets 03:59:42 2024-04-26 pm EDT			5-day change	1st Jan Change
14.37 ^CAD	+4.13%		-3.43%	+109.78%

Apr. 22	Trulieve Cannabis Brief: Opening Medical Cannabis Dispensary in North Palm Beach, Florida	MT
Apr. 22	Trulieve to Open Medical Cannabis Dispensary in North Palm Beach, Florida	CI

Trulieve Cannabis Corp. Provides Earnings Guidance for the First Quarter of 2024

February 29, 2024 at 06:36 am EST

Trulieve Cannabis Corp. provided earnings guidance for the first quarter of 2024. For the quarter, the company expects revenue to be similar to the fourth quarter of 2023.

Latest news about Trulieve Cannabis Corp.

Trulieve Cannabis Brief: Opening Medical Cannabis Dispensary in North Palm Beach, Florida	Apr. 22	MT
Trulieve to Open Medical Cannabis Dispensary in North Palm Beach, Florida	Apr. 22	CI
Pot producers climb as recreational cannabis to go on Florida ballot	Apr. 02	RE
Trulieve Cannabis Brief: Opening Medical Cannabis Dispensary in Cocoa Beach, Florida	Mar. 26	MT
Trulieve Cannabis Corp. to Open Medical Cannabis Dispensary in Cocoa Beach, Florida	Mar. 26	CI
Cannabis Stocks Gain Following Rumors of Imminent Rescheduling	Mar. 15	DJ
Cannabis Stocks Retreat After WSJ Report of DEA Concerns	Mar. 11	DJ
Cannabis Shares Gain After Biden Says Marijuana Laws Should Be Loosened	Mar. 08	DJ
Trulieve Cannabis Corp. to Open Express Medical Cannabis Dispensary in Palm Bay, Florida	Mar. 06	CI
Trulieve Cannabis Brief: Opening Express Medical Cannabis Dispensary in Palm Bay, Florida	Mar. 06	MT
Trulieve Cannabis Rises 4% As Trims Q4 2023 Adjusted Net Loss Q4 YOY	Feb. 29	MT
Trulieve Cannabis Trims Q4 2023 Adjusted Net Loss Q4 YOY	Feb. 29	MT
Transcript : Trulieve Cannabis Corp., Q4 2023 Earnings Call, Feb 29, 2024	Feb. 29
Trulieve Cannabis Corp. Reports Earnings Results for the Full Year Ended December 31, 2023	Feb. 29	CI
Trulieve Cannabis Corp. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Feb. 29	CI
Trulieve Cannabis Corp. Provides Earnings Guidance for the First Quarter of 2024	Feb. 29	CI
Trulieve Cannabis Brief: Expecting 2024 cash flow from operations of at least US$225 million	Feb. 29	MT
Trulieve Cannabis Brief: Q4 Reported net loss of US$33 million; Says Adjusted net loss of $23 million excludes non-recurring charges, asset impairments, disposals and discontinued operations	Feb. 29	MT
Trulieve Cannabis Brief: Q4 Revenue of US$287 million increased 4% sequentially, with 95% of revenue from retail sale	Feb. 29	MT
Trulieve Cannabis Corp. to Open Medical Cannabis Dispensary in Pinellas Park, Florida	Feb. 20	CI
Trulieve Cannabis Opens New Dispensary In Florida	Feb. 20	MT
SLANG Worldwide Inc. Launches O.pen in Arizona Through Trulieve Cannabis Corp. Strategic Partnership	Jan. 17	CI
Trulieve Cannabis Names Chief Operating Officer; Up 4.6%	Jan. 12	MT
Trulieve Cannabis Names Chief Operating Officer	Jan. 12	MT
Trulieve Announces Appointment of Marie Zhang as Chief Operating Officer, Effective January 29, 2024	Jan. 12	CI

Trulieve Cannabis Corp. is a vertically integrated cannabis company. The Company has established cannabis operations in three hubs: Southeast, Northeast, and Southwest. Its three regional hubs are anchored by market positions in cornerstone states of Florida, Pennsylvania, and Arizona. The Company operates in regulated markets that require knowledge in cultivation, manufacturing, and retail. The Company utilizes various extraction techniques, including critical ethanol extraction, carbon dioxide extraction, hydrocarbon extraction, and mechanical separation. In addition, the Company owns and utilizes carbon dioxide extraction, distillation, purification and manufacturing technology that is used to produce a range of cannabis topicals and vapes featuring cannabinoids. The Company's brands include premium tier brands Avenue, Cultivar Collection, and Muse; mid-tier brands Modern Flower, Alchemy, Momenta, and Sweet Talk, and value tier brands Co2lors, Loveli, Roll One, and Trekkers.

Sector

Pharmaceuticals

Calendar

2024-05-09 - Q1 2024 Earnings Release

More about the company